换一批
换一批Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease.
作者：
主题词
青少年(Adolescent);成年人(Adult);抗体, 抗独特型(Antibodies, Anti-Idiotypic);抗体, 单克隆(Antibodies, Monoclonal);队列研究(Cohort Studies);结肠炎, 溃疡性(Colitis, Ulcerative);Crohn病(Crohn Disease);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);药物释放系统(Drug Delivery Systems);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);炎性肠疾病(Inflammatory Bowel Diseases);男(雄)性(Male);概率(Probability);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);敏感性与特异性(Sensitivity and Specificity);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome);肿瘤坏死因子α(Tumor Necrosis Factor-alpha);青年人(Young Adult)
DOI
10.1038/ajg.2010.9
PMID
20145610
发布时间
2022-03-10
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
